Squamous Intraepithelial Lesions of the Cervix clinical trials
The registry lists 5 studies for Squamous Intraepithelial Lesions of the Cervix across 4 countries. 4 are recruiting or about to start. 3 of them are mainly about Squamous Intraepithelial Lesions of the Cervix (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-02.
Get an email when these change. Save the Squamous Intraepithelial Lesions of the Cervix studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Miquel Angel Pavon Ribas (1) · Institut d'Investigació Biomèdica de Bellvitge (1) · Centre Hospitalier Régional d'Orléans (1) · National Cancer Institute (NCI) (1) · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2
- Dec 2026A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV) · Miquel Angel Pavon Ribas
- Feb 2027Study Assessing Reduced HPV Infectivity and Transmission in HPV-Positive Women Following Vaccination With 9vHPV · Institut d'Investigació Biomèdica de Bellvitge
Who these studies take
Of the 2 Squamous Intraepithelial Lesions of the Cervix studies recruiting now, 2 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (50%) take children under 18. 2 (100%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (50%) | 0 (0%) |
| 18 | 2 (100%) | 0 (0%) |
| 30 | 2 (100%) | 0 (0%) |
| 40 | 2 (100%) | 0 (0%) |
| 50 | 2 (100%) | 0 (0%) |
| 65 | 2 (100%) | 0 (0%) |
| 75 | 2 (100%) | 0 (0%) |
| 85 | 2 (100%) | 0 (0%) |
Across all 5 studies, recruiting or not: 20% stop at 75 or younger and 20% at 65; 20% take children; 80% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 5 of 5. search them.
- Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology StudiesEnrolling by invitationNCT042660931 country
- A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV)RecruitingNCT05334706Phase 41 country
- Study Assessing Reduced HPV Infectivity and Transmission in HPV-Positive Women Following Vaccination With 9vHPVNot yet recruitingNCT07303751Phase 21 country
- Conservative Management of HSIL in Patients With Future Pregnancy AspirationRecruitingNCT047838051 country
- Papilocare®: Effects on Regression of Histologically Confirmed Cervical Intraepithelial Lesions 1 and ToleranceCompletedNCT04624568Not applicable1 country